Are insulin receptors clinically significant?

Area of Science:

• Endocrinology
• Metabolic Disorders

Background:

• Clinical diabetes mellitus pathophysiology was largely understood prior to the discovery of insulin receptors.
• Type I diabetes (growth-onset) is characterized by primary beta-cell failure with normal insulin sensitivity and receptor levels.
• Type II diabetes (adult-onset) involves a combination of insulin deficiency and resistance, leading to hyperinsulinemia.

Purpose of the Study:

• To elucidate the roles of insulin receptors and post-receptor defects in different types of diabetes mellitus.
• To re-evaluate the significance of the insulin hormone versus its receptor in diabetes pathogenesis.

Main Methods:

• Review and synthesis of existing knowledge on diabetes mellitus pathophysiology.
• Analysis of the relationship between beta-cell function, insulin sensitivity, insulin receptor concentration, and clinical presentation in Type I and Type II diabetes.

Main Results:

• Type I diabetes is primarily a beta-cell defect, independent of insulin receptor abnormalities.
• Type II diabetes exhibits secondary downregulation of insulin receptors due to chronic hyperinsulinemia.
• Obesity exacerbates hyperinsulinemia in Type II diabetes but insulin levels decrease as the disease progresses.

Conclusions:

• Post-receptor defects in glucose transport and intracellular insulin action are critical and linked to impaired insulin secretion.
• The insulin hormone itself plays a more central role in diabetes than its receptor.
• Further research is needed to fully understand post-receptor signaling pathways and their relation to insulin secretion defects.